| [1] |
Zhang M, Zhu XX, Wu J, et al. Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19[J]. Front Immunol, 2022, 12: 791983.
doi:10.3389/fimmu.2021.791983URL |
| [2] |
Yu KH, Chen DY, Chen JH, et al. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan[J]. Int J Rheum Dis, 2018. 21(4): 772-787.
doi:10.1111/1756-185X.13266URL |
| [3] |
White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout[J]. N Engl J Med, 2018, 378(13): 1200-1210.
doi:10.1056/NEJMoa1710895URL |
| [4] |
Zhang M, Solomon DH, Desai RJ, et al. Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol[J]. Circulation, 2018, 138(11): 1116-1126.
doi:10.1161/CIRCULATIONAHA.118.033992URL |
| [5] |
Chen CH, Chen CB, Chang CJ, et al. Hypersensitivity and cardiovascular risks related to allopurinol and febuxostat therapy in Asians[J]. Clin Pharmacol Ther, 2019, 106(2): 391-401.
doi:10.1002/cpt.1377URL |
| [6] |
Mackenzie IS, Ford I, Nuki G, et al. Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout(FAST)[J]. Lancet, 2020, 396(10264): 1745-1757.
doi:10.1016/S0140-6736(20)32234-0pmid:33181081 |
| [7] |
Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction[J]. N Engl J Med, 2019, 381(26): 2497-2505.
doi:10.1056/NEJMoa1912388URL |
| [8] |
Shah B, Toprover M, Crittenden DB, et al. Colchicine use and incident coronary artery disease in male patients with gout[J]. Can J Cardiol, 2020, 36(11): 1722-1728.
doi:10.1016/j.cjca.2020.05.026URL |
| [9] |
Yamanaka H, Tamaki S, Ide Y, et al. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study[J]. Ann Rheum Dis, 2018, 77(2): 270-276.
doi:10.1136/annrheumdis-2017-211574pmid:29102957 |
| [10] |
Xue X, Liu Z, Li X, et al. The efficacy and safety of citrate mixturevssodium bicarbonate on urine alkalization in Chinese primary gout patients with benzbromarone: a prospective, randomized controlled study[J]. Rheumatology (Oxford), 2021, 60(6): 2661-2671.
doi:10.1093/rheumatology/keaa668URL |
